Drug Database
Back to search

Czechia· CZ-0000612

SYNTOSTIGMIN

A neostigmine product containing neostigmine metilsulfate, registered in Czechia by BB Pharma a.s., Praha. The same ATC class is registered in 10 of our 19 countries.

ATC N07AA01

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedSYNTOSTIGMINATCN07AA01REGISTER NO.CZ-0000612PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about neostigmine metilsulfateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Neostigmine is registered in 10 of 19 countries.

Countries holding a registration under ATC N07AA01 (neostigmine), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 6 of them publish a price we can compare per daily dose
Search neostigmine products by name

Neostigmine · ATC N07AA01

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
NEOSTIGMINE METILSULFATE
Manufacturer
BB Pharma a.s., Praha
Country
Czechia (CZ)
ATC code
N07AA01
ATC class
Neostigmine
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0000612
    10X1ML
    CZK 131.71

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

68 interactions on record for neostigmine.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check neostigmine against other medicinesHow interaction checks work

Neostigmine · interactions on record

68 records

  • 6 severe
  • 62 moderate

Most severe, free to view

  • SiponimodL04AA42severe
  • SiponimodL04AE03severe
  • BupropionN06AX12severe
  • BupropionN07BA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Neostigmine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All neostigmine products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Neostig, Normastigmin
  • Cyprus · Neostigmine Cooper
  • Germany · Neostig, Neostigmin Panpharma
  • Spain · Neostigmina Braun
  • France · Néostigmine Renaudin, Prostigmine
  • United Kingdom (Northern Ireland) · Neostigmine Methylsulfate Bp Hameln Pharma
  • Greece · Neostigmine Cooper
  • Croatia · Neostigmin Panpharma
  • Hungary · Neostigmine Kalceks, Stigmosan
  • Latvia · Neostigmine Kalceks
  • Netherlands · Neostigminemethylsulfaat Cf, Prostigmin
  • Poland · Polstigminum
  • Portugal · Neostigmina Braun
  • Romania · Miostin
  • Sweden · Neostigmin Unimedic Pharma Ab
  • Slovakia · Syntostigmin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b5251e97-9606-42a8-a7d7-23e74c41c85e
GET /v1/drugs/b5251e97-9606-42a8-a7d7-23e74c41c85e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ SOL",
  "source": "sukl",
  "strength": "0,5MG/ML",
  "pack_size": "10X1ML",
  "substance": "NEOSTIGMINE METILSULFATE",
  "cz_kod_sukl": "0000612",
  "product_type": "CH",
  "substance_codes": "2465",
  "registration_state": "R",
  "registration_number": "67/771/92-S/C"
}
API referenceMCP serverPlans

See everything about neostigmine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console